Monsanto Loses EU Patent Case
07 July, 2010
BRUSSELS—The European Court of Justice Tuesday ruled that European Union patent law can't be used to bar imports of products made from biotech ingredients that are patented in the EU but not in the exporting country.
The decision could open the door for increased exports to the EU by producers of biotech products in emerging-market countries that have weaker patent protection.
"This will affect all inventions where genetically active material is used as a method or product," said Arnout Gieske, a patent lawyer with Amsterdam-based Van Diepen Van der Kroef.
←ING Groep Selling Canadian Commercial Real Estate Portfolio, Globe SaysDutch Court Orders Van der Moolen Investigation→↑News↑